Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Poster presentation

Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation

Noboru Taniguchi12*, Beatriz Caramés2, Yasuhiko Kawakami3 and Martin Lotz2

  • * Corresponding author: Noboru Taniguchi

Author Affiliations

1 Hakuaikai Kaisei Hospital, Obihiro, Hokkaido, Japan

2 The Scripps Research Institute, La Jolla, CA, USA

3 University of Minnesota, Minneapolis, MN, USA

For all author emails, please log on.

Arthritis Research & Therapy 2012, 14(Suppl 1):P68  doi:10.1186/ar3669


The electronic version of this article is the complete one and can be found online at: http://arthritis-research.com/content/14/S1/P68


Published:9 February 2012

© 2012 Taniguchi et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Poster presentation

The superficial zone (SZ) of articular cartilage is critical in maintaining tissue function and homeostasis and represents the site of the earliest changes in osteoarthritis (OA). The expression of chromatin protein HMGB2 is restricted to the SZ, which contains cells expressing mesenchymal stem cell (MSC) markers [1]. Aging-related loss of HMGB2 and gene deletion are associated with reduced SZ cellularity and early onset OA [2]. This study addressed HMGB2 expression patterns in MSC and its role during differentiation.

HMGB2 was detected at higher levels in human MSC as compared to human articular chondrocytes and its expression declined during chondrogenic differentiation of MSC (Figure 1). Lentiviral HMGB2 transduction of MSC suppressed chondrogenesis as reflected by an inhibition of Col2a1 and Col10a1 expression. Conversely, in bone marrow MSC from Hmgb2-/- mice, Col10a1 was more strongly expressed than in wildtype MSC. This is consistent with in vivo results from mouse growth plates showing that Hmgb2 is expressed in proliferating and prehypertrophic zones but not in hypertrophic cartilage where Col10a1 is strongly expressed. Osteogenesis was also accelerated in Hmgb2-/- MSC. The expression of Runx2, which plays a major role in late stage chondrocyte differentiation, was enhanced in Hmgb2-/- MSC and HMGB2 negatively regulated the stimulatory effect of Wnt/β-catenin signaling on the Runx2 proximal promoter.

thumbnailFigure 1. HMGB2 expression during chondrogenesis of human MSC. Immunohistochemistry shows that HMGB2 is expressed at days 1 and 3, but that expression is reduced at days 7, 14 upon induction of chondrogenesis. SO: safranin O staining.

These results demonstrate that HMGB2 expression is inversely correlated with the differentiation status of MSC and that HMGB2 suppresses chondrogenic differentiation. The aging-related loss of HMGB2 in articular cartilage may represent a mechanism responsible for the decline in adult cartilage stem cell populations.

References

  1. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ, Haughton L, Bayram Z, Boyer S, Thomson B, et al.: The surface of articular cartilage contains a progenitor cell population.

    J Cell Sci 2004, 117(Pt 6):889-897. PubMed Abstract | Publisher Full Text OpenURL

  2. Taniguchi N, Carames B, Ronfani L, Ulmer U, Komiya S, Bianchi ME, Lotz M: Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis.

    Proc Natl Acad Sci USA 2009, 106(4):1181-1186. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL